The Pictet GSF Biotech is a Luxembourg investment fund that invests in the global biopharmaceutical ...
The Pictet GSF Biotech is a Luxembourg investment fund that invests in the global biopharmaceutical sector. The dollar-denominated fund, listed on the Luxembourg Stock Exchange, was launched in March 1995 and is co-managed by Michael Sjöström and Vincent Ossipow. The fund also has a five-strong scientific advisory board, made up of experts in the fields of neurology, cardiology and oncology. Sjöström said: "The fund is a bottom-up fund. It focuses on stock selection and that process is done by myself and Ossipow." The two managers complement each other, Sjöström having an expertise in f...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes